All terms in EFO
| Label | Id | Description |
|---|---|---|
| obsolete_postaxial polydactyly type B, unilateral | Orphanet_295167 | |
| Anilide use measurement | EFO_0009938 | [Quantification of some aspect of the use of anilide drugs.] |
| Juvenile Xanthogranuloma | EFO_1000311 | [A benign histiocytic tumor that occurs during childhood; it is distinct from Langerhans cell histiocytosis. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells in the dermis. The lesions usually develop during infancy. They consist of cutaneous papules and nodules (most often in the head and neck). It is sometimes associated with deep soft tissues nodules.] |
| Antimigraine preparation use measurement | EFO_0009939 | [Quantification of some aspect of the use of antimigraine preparations.] |
| Kidney Angiomyolipoma | EFO_1000312 | [An angiomyolipoma arising from the kidney.] |
| obsolete_postaxial polydactyly type A, bilateral | Orphanet_295165 | |
| Thyroid preparation use measurement | EFO_0009933 | [Quantification of some aspect of the use of thyroid preparations.] |
| Immunosuppressant use measurement | EFO_0009934 | [Quantification of some aspect of the use of immunosuppressant drugs.] |
| Non-steroidal anti-inflammatory and antirheumatic product use measurement | EFO_0009935 | [Quantification of some aspect of the use of non-steroidal anti-inflammatory and antirheumatic product.] |
| obsolete_postaxial polydactyly type B, bilateral | Orphanet_295169 | |
| Drugs affecting bone structure and mineralization use measurement | EFO_0009936 | [Quantification of some aspect of the use of drugs affecting bone structure and mineralization.] |
| trans-4-hydroxy-L-proline | CHEBI_18095 | [An optically active form of 4-hydroxyproline having L-trans-configuration.] |
| lower face morphology measurement | EFO_0010948 | [Quantification of some aspect of lower face morphology such as chin protrusion.] |
| C57BL/6JxCAST/EiJ | EFO_0010946 | [A Mus musculus individual that is a substrain of C57BL/6J (mother) and CAST/EiJ (father).] |
| epidermal growth factor measurement | EFO_0010947 | [The determination of the amount of epidermal growth factor present in a sample.] |
| CAST/EiJxC57BL/6J | EFO_0010945 | [A Mus musculus individual that is a substrain of CAST/EiJ (mother) and C57BL/6J (father).] |
| primary tumor sample | EFO_0010942 | [A neoplastic sample derived from a primary tumor (not from a cancer metastasis).] |
| recurrent tumor sample | EFO_0010943 | [A neoplastic sample derived from a recurrent tumor (not from a primary occurrence of a neoplasm).] |
| response to radioiodine | EFO_0009962 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a radioiodine stimulus. Radioiodine may refer to any isotope of the element iodine that undergoes radioactive decay. Some radioactive iodine isotopes are used to treat diseases of the thyroid.] |
| response to radiation | GO_0009314 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus.] |